Allison Ruth Larson

Allison Ruth Larson

Auto-generated profile, based on publicly available information

Allison Ruth Larson

Department of Dermatology, Boston University School of Medicine, Boston, Massachusetts

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2012 in Cell
Verified
Journal Article
Closed access
CLChristine Lian
Christine Lian
YXYufei Xu
Yufei Xu
CCCraig Ceol
Craig Ceol
FWFeizhen Wu
Feizhen Wu
ALAllison Larson
Allison Larson
YSYujiang Shi
Yujiang Shi

3 January 2014 in Laboratory Investigation
Verified
Journal Article
Open access
PDF file
ALAllison R Larson
Allison R Larson
KDKaren A Dresser
Karen A Dresser
QZQian Zhan
Qian Zhan
CLCecilia Lezcano
Cecilia Lezcano
BWBruce A Woda
Bruce A Woda
CLChristine Lian
Christine Lian
DNA methylation is the most well-studied epigenetic modification in cancer biology. 5-hydroxymethylcytosine is an epigenetic mark that can be converted from 5-methylcytosine by the ten-eleven translocation gene family. We recently reported the loss of 5-hydroxymethylcytosine in melanoma compared with benign nevi and suggested that loss of this epigenetic marker is correlated with tumor virulence based on its association with a worse prognosis. In this study, we further characterize the immunoreactivity patterns of 5-hydroxymethylcytosine in the full spectrum of melanocytic lesions to further validate the potential practical application of this epigenetic marker. One hundred and seventy-five cases were evaluated: 18 benign nevi, 20 dysplastic nevi (10 low-grade and 10 high-grade lesions), 10 atypical Spitz nevi, 20 borderline tumors, 5 melanomas arising within nevi, and 102 primary melanomas. Progressive loss of 5-hydroxymethylcytosine from benign dermal nevi to high-grade dysplastic nevi to borderline melanocytic neoplasms to melanoma was observed. In addition, an analysis of the relationship of nuclear diameter with 5-hydroxymethylcytosine staining intensity within lesional cells revealed a significant correlation between larger nuclear diameter and decreased levels of 5-hydroxymethylcytosine. Furthermore, borderline lesions uniquely exhibited a diverse spectrum of staining of each individual case. This study further substantiates the association of 5-hydroxymethylcytosine loss with dysplastic cytomorphologic features and tumor progression and supports the classification of borderline lesions as a biologically distinct category of melanocytic lesions.

1 October 2009 in Plastic and Reconstructive Surgery
Verified
Journal Article
Closed access
GRGedge D. Rosson
Gedge D. Rosson
ALAllison R. Larson
Allison R. Larson
EWEric H. Williams
Eric H. Williams
ADA Lee Dellon
A Lee Dellon
The anatomical basis for the surgical techniques used to treat tarsal tunnel syndrome is not well studied. The authors sought to evaluate their hypotheses that (1) pronation and pronation with plantar flexion of the intact foot would have higher pressures than the intact foot in other positions; (2) decompression surgery would significantly lower the pressure in all three tunnels in all foot positions, and roof incision plus septum excision would lower the pressure further in some positions; and (3) the pressures in symptomatic patients would be significantly higher than those in an analogous cadaver study. In 10 patients with tarsal tunnel syndrome, the authors intraoperatively measured pressures in the tarsal, medial plantar, and lateral plantar tunnels in multiple foot positions before and after excision of the tunnel roofs and intertunnel septum. The authors found that (1) pronation and plantar flexion significantly increased pressures in the medial and lateral plantar tunnels, to levels sufficient to cause chronic nerve compression; (2) tunnel release and septum excision significantly decreased those pressures; and (3) compared with cadaver pressures, patients had similar tarsal tunnel pressures but higher lateral plantar tunnel pressures in some positions. Many surgeons operating on patients with tarsal tunnel syndrome do not decompress the respective medial plantar and lateral plantar nerves and excise the septum. The authors' study validates the hypotheses that patients who are clinically suspected of having chronic compression of the tibial nerve and its branches at the ankle have higher tunnel pressures and that releasing these structures decreases the pressures.


17 May 2019 in Journal of Women's Health
Verified
Journal Article
Closed access
ALAllison R. Larson
Allison R. Larson
CKCarolyn K. Kan
Carolyn K. Kan
JSJulie K. Silver
Julie K. Silver
Background: Among U.S. medical school deans, there is a wide gender gap, most prominent at the highest levels. We aimed to discover how well women physicians were represented within the pool of women deans compared with the pool of men deans. Materials and Methods: A cross-sectional study was performed on 149 allopathic medical schools in the United States. For each school, information was collected on deans' names, titles, genders, and degree(s). Chi-square analyses were performed to determine association between gender and dean ranks. Results: Of the 2559 deans included from 149 medical schools, 1649 (64.4%) were physicians, and of these, women physicians accounted for 634 (38.4%), a significant under-representation ( p < 0.00001). In comparison, the 626 nonphysician doctorate-holders of which women accounted for 291 (46.5%, p = 0.061) were equally represented. Of the 284 deans with bachelor's or master's degrees, women accounted for 180 (63.4%), a significant over-representation ( p < 0.00001). This difference was most profound at the lower tier (assistant) dean level. A lower tier physician dean was 1.25 times more likely to be a man than a woman, and a higher tier (dean of medical school, senior associate, vice, or associate) physician dean was 1.16 times more likely to be a man. Conclusions: Women physicians were under-represented among medical school deans compared with men. This disparity held among lower tier and higher tier deans.

23 December 2008 in Nature Clinical Practice Oncology
Verified
Journal Article
Closed access
PDF file
ALAllison R Larson
Allison R Larson
EKEliz Konat
Eliz Konat
RARhoda M Alani
Rhoda M Alani